Medpace Holdings Inc (MEDP)
305.76
-4.87
(-1.57%)
USD |
NASDAQ |
Nov 18, 12:18
Medpace Holdings Net Income (Quarterly): 96.43M for Sept. 30, 2024
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
Date | Value |
---|---|
September 30, 2024 | 96.43M |
June 30, 2024 | 88.35M |
March 31, 2024 | 102.59M |
December 31, 2023 | 78.30M |
September 30, 2023 | 70.55M |
June 30, 2023 | 61.07M |
March 31, 2023 | 72.89M |
December 31, 2022 | 68.67M |
September 30, 2022 | 66.03M |
June 30, 2022 | 49.36M |
March 31, 2022 | 61.31M |
December 31, 2021 | 50.03M |
September 30, 2021 | 48.57M |
June 30, 2021 | 39.93M |
March 31, 2021 | 43.31M |
December 31, 2020 | 50.87M |
September 30, 2020 | 41.46M |
June 30, 2020 | 24.10M |
March 31, 2020 | 28.95M |
December 31, 2019 | 29.81M |
Date | Value |
---|---|
September 30, 2019 | 23.98M |
June 30, 2019 | 27.46M |
March 31, 2019 | 19.20M |
December 31, 2018 | 22.76M |
September 30, 2018 | 19.30M |
June 30, 2018 | 16.57M |
March 31, 2018 | 14.55M |
December 31, 2017 | 11.29M |
September 30, 2017 | 9.831M |
June 30, 2017 | 9.553M |
March 31, 2017 | 8.447M |
December 31, 2016 | -0.021M |
September 30, 2016 | 5.036M |
June 30, 2016 | 4.962M |
March 31, 2016 | 3.448M |
December 31, 2015 | -8.576M |
September 30, 2015 | -0.133M |
June 30, 2015 | 0.095M |
March 31, 2015 | -0.059M |
March 31, 2014 | -1.236M |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (Quarterly) Range, Past 5 Years
24.10M
Minimum
Jun 2020
102.59M
Maximum
Mar 2024
58.63M
Average
55.97M
Median
Net Income (Quarterly) Benchmarks
Globus Medical Inc | 51.84M |
IQVIA Holdings Inc | 285.00M |
Fortrea Holdings Inc | -27.90M |
CEL-SCI Corp | -6.857M |
AIM ImmunoTech Inc | -1.836M |
Net Income (Quarterly) Related Metrics
Revenue (Quarterly) | 533.32M |
Total Expenses (Quarterly) | 421.04M |
EPS Diluted (Quarterly) | 3.01 |
Enterprise Value | 8.998B |
Gross Profit Margin (Quarterly) | 31.69% |
Profit Margin (Quarterly) | 18.08% |
Earnings Yield | 3.73% |
Operating Earnings Yield | 4.18% |
Normalized Earnings Yield | 3.735 |